NorthEdge Invests in ramarketing
April 20, 2022
NorthEdge has completed a growth investment in ramarketing, a life-sciences-focused full-service marketing agency, to support international expansion and service capability growth. The backing will help ramarketing expand its US footprint, enhance its creative, content and digital offerings, and continue hiring across its Newcastle, Manchester and Boston offices.
- Buyers
- NorthEdge
- Targets
- ramarketing
- Industry
- Marketing & Advertising
- Location
- England, United Kingdom
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
NorthEdge Invests in Helios Medical Communications
January 14, 2021
Healthcare Services
NorthEdge, a UK private equity firm, has made a growth investment in Helios Medical Communications to support the agency's UK and international expansion plans. The Cheshire-headquartered medical communications agency will use the funding to expand offices (including a new Manchester location), recruit talent, and pursue international growth; NorthEdge partners will join the Helios board.
-
NorthEdge Completes Multi‑Million‑Pound Investment into Antibody Analytics
November 2, 2023
Biotechnology
NorthEdge has completed a multi‑million‑pound growth investment in Antibody Analytics (now trading as RoukenBio), a Scotland‑based pre‑clinical immunology CRO. The capital will fund site expansion, upgraded facilities and job creation as NorthEdge (represented on the board by Liam May) backs CEO Andy Upsall and the leadership team to scale the business internationally.
-
NorthEdge Capital Invests in CMAP
January 7, 2020
Cloud & SaaS
NorthEdge Capital has made a multi-million pound growth investment in CMAP, a Wilmslow-based SaaS company that provides cloud-based project management software. The funding will support product development, scale the team (currently ~50 employees) and accelerate CMAP's expansion in the US and other international markets.
-
NorthEdge Invests in Torbay Pharmaceuticals
November 20, 2023
Pharmaceuticals
NorthEdge has acquired Torbay Pharmaceuticals, a UK-based sterile injectable contract manufacturer, from Torbay and Devon NHS Foundation Trust to support the company's next phase of international growth. The investment (funded by NorthEdge Fund III) will back expansion into North America, strengthen fill/finish and plastic vial capabilities, increase automation, and support growth of Torbay's c.250-strong team at its Paignton, Devon HQ.
-
Horizon Capital Invests in The Marketing Practice
April 7, 2021
Marketing & Advertising
London-based private equity firm Horizon Capital has made a significant investment in B2B marketing agency The Marketing Practice to support its account-based marketing, demand generation and data capabilities. The funding will be used to deepen the agency's technology and data expertise and support further global expansion across its offices in the UK, US, Germany and Australia.
-
NorthEdge Backs Management Buyout of ICP
December 16, 2021
Marketing & Advertising
NorthEdge has backed a primary management buyout of London-based marketing consultancy ICP, with CEO Christopher Grakal and the firm's management team participating. The investment will fund ICP's international growth, new service launches and team expansion while founder Adrian Smith steps down as Chair.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.